Michael Turner
Academic Clinical Lecturer
BA(Hons) BMBCh MSc DPhil MRCP(UK) AFHEA
Michael studied Medicine in Oxford and has undertaken postgraduate training in Manchester and the Thames Valley. He completed an MSc in Global Health Science between core and specialty training and took time out from general (internal) medicine and renal medicine specialty training to complete a DPhil in Population Health Science.
Michael’s DPhil examined the genetics of blood pressure in the Mexico City Prospective Study (MCPS) of 150 000 adults. He explored haplotype-based methods to describe the complex population structure in MCPS and then examined the genetic determinants (through genome-wide association studies) and consequences (through Mendelian randomisation studies) of elevated blood pressure.
During his clinical lectureship, Michael hopes to build on his previous work and examine the role that major risk factors play in multi-morbidity in MCPS, explore the causes and consequences of kidney disease in MCPS, and gain experience in the clinical trials that the department leads. He is experienced in teaching epidemiology and statistical coding to MSc and clinical medical students.
Recent publications
-
Blood Pressure, eGFR, and Kidney Mortality in Mexico: A Prospective Study of 150,000 Adults
Conference paper
Zhu D., (2024)
-
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2024), Nature, 626
-
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2023), Nature, 622, 784 - 793
-
MCPS Genetic Cohort Profile code
Software / Code
TORRES J. and TURNER M., (2023)
-
Mendelian randomization study of the relevance of blood pressure to vascular mortality among 150,000 participants in the mexico city prospective study
Conference paper
Turner M. et al, (2023), EUROPEAN HEART JOURNAL, 44